ArticleEndocrine2025
Impact of delayed surgery in differentiated thyroid carcinoma and medullary thyroid carcinoma.
Article in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Individualized survival prediction in medullary thyroid carcinoma using a least absolute shrinkage and selection operator-Cox-based nomogram.The Journal of international medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDelay in surgery and the impact on survival in thyroid cancer is unclear. We sought to investigate the association between time to surgery and survival in patients with differentiated thyroid carcinoma (DTC) or medullary thyroid carcinoma (MTC).
methodsIn this retrospective study, we included patients who were diagnosed with DTC(including papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC) and oncocytic thyroid carcinoma (OTC)) or MTC between 2000 and 2021. Data was gathered from the Surveillance, Epidemiology and End Results (SEER) database. And we defined the cutoff period for delayed surgery of DTC was 3 months, while 2 months for MTC. Kaplan-Meier method and log-rank test were used to analyze overall survival (OS) and cancer-specific survival (CSS).
results181588 patients were included in our study. Of which 165,202 (91.0%) were diagnosed with PTC, 9525 (5.2%) were FTC, 4128 (2.3%) were OTC and 2733 (1.5%) were MTC. Comparison of clinical paraments between delayed and non-delayed patients of the four types of thyroid cancer indicated that delayed surgery may alter the clinical characteristics, leading to tumor progression or increased aggressiveness, especially for lymph node metastasis. Meanwhile, delayed surgery (≥3 months) was associated with decreased survival in PTC and FTC, not for OTC. For MTC, delayed surgery (≥2 months) was associated with poorer OS. Additionally, we analyzed the trends in delayed surgery and found that except for an upward trend in PTC, other pathological types showed no significant fluctuations.
conclusionsDelaying surgery for DTC and MTC should be avoided, as this could lead to tumor progression or more aggressive behavior and poorer prognosis.
Indexed as
Identifiers
40272725What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.